RESUMEN
ABSTRACT: This is the first report of pediatric catatonia syndrome in MED13L haploinsufficiency syndrome. This report describes unique challenges in diagnosis and management of catatonia in rare genetic conditions. The case also illustrates the use of electroconvulsive therapy in patients with epilepsy, epileptic encephalopathy, or other epileptic diathesis and the clinical conundrum in determining the course of maintenance electroconvulsive therapy.
Asunto(s)
Catatonia , Terapia Electroconvulsiva , Epilepsia , Haploinsuficiencia , Adolescente , Humanos , Masculino , Catatonia/terapia , Catatonia/genética , Catatonia/complicaciones , Epilepsia/genética , Epilepsia/complicaciones , Epilepsia/terapia , Complejo Mediador/genéticaRESUMEN
The cannabis plant is the most used federally illegal drug in the United States and is widely used by adolescents. Cannabis has complex effects on the body and mind. All health professionals who take care of adolescents with cystic fibrosis (CF) should be aware of the factors impacting cannabis use in CF. Given limited evidence regarding the benefits of cannabis and the significant risks, clinicians have the responsibility to identify risk of cannabis use early, counsel patients about the risks, provide a safe space for ongoing conversations about cannabis use in the context of CF care, and deliver evidence-based interventions.